Reply to Walker et al
Author(s) -
Seth T. Walk,
Dejan Micić,
Andrzej T. Gałecki,
Mary A.M. Rogers,
Laraine Washer,
David W. Newton,
Preeti Malani,
Vincent B. Young,
David M. Aronoff
Publication year - 2013
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/cit099
Subject(s) - clostridium difficile , covariate , medicine , biology , statistics , microbiology and biotechnology , antibiotics , mathematics
To the Editor—We thank Walker et al for their interest in our work [1]. Our study found no evidence of difference in clinical severity of Clostridium difficile infection (CDI) between patients infected with ribotype 027/078 strains compared with others, when adjusted for other covariates [2]. Adjustment for factors on the hypothesized causal pathway between exposure (ribotype) and outcome (severity), such as leukocyte count, has been addressed elsewhere [3]. Removing the leukocyte count as a covariate or including it in the definition of severe disease did not alter our findings [3].
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom